Please confirm topic selection

Are you sure you want to trigger topic in your Anconeus AI algorithm?

Please confirm action

You are done for today with this topic.

Would you like to start learning session with this topic items scheduled for future?

  • Snapshot
    • A 50-year-old woman presents to her dermatologist for a rash of 1 week duration. She is noted to have erosions with crusting of the advancing edge, glossitis, and angular cheilitis. Her dermatologist notes that this rash is consistent with necrolytic migratory erythema, a condition seen in patients with glucagonomas. On laboratory evaluation, the patient has hyperglycemia and increased levels of glucagon. She is referred to oncology and started on octreotide.
  • Introduction
    • Drugs
      • octreotide
    • Mechanism of action
      • octreotide is a somatostatin analog
        • inhibits secretion of splanchnic vasodilatory hormones
          • growth hormone
          • gastrin
          • vasoactive intestinal peptide (VIP)
          • glucagon
          • secretin
          • serotonin
          • pancreatic polypeptide
    • Clinical use
      • acute variceal bleeds
      • acromegaly
      • VIPoma
      • carcinoid tumors
      • glucagonoma
      • other neuroendocrine tumors
    • Adverse effects
      • gastrointestinal upset
      • steatorrhea
      • inhibits cholecystokinin, which increases the risk of cholelithiasis and cholecystitis
      • bradycardia
1 of 0
Private Note

Attach Treatment Poll
Treatment poll is required to gain more useful feedback from members.
Please enter Question Text
Please enter at least 2 unique options
Please enter at least 2 unique options
Please enter at least 2 unique options